Niacin stimulates adiponectin secretion through the GPR109A receptor
about
Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyDietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseasesEmerging preclinical pharmacological targets for Parkinson's diseaseNiacin, an old drug with a new twistThe therapeutic role of niacin in dyslipidemia managementAnti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms.Oral β-hydroxybutyrate increases ketonemia, decreases visceral adipocyte volume and improves serum lipid profile in Wistar rats.Screening of Different Organs of Rats for HCA2 Receptor mRNALack of association between body mass index and plasma adiponectin levels in healthy adults.Future of GPR109A agonists in the treatment of dyslipidaemia.Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.Pharmacological effects of lipid-lowering drugs on circulating adipokines.Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed miceA microfluidic interface for the culture and sampling of adiponectin from primary adipocytes.Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.Effects of niacin on atherosclerosis and vascular function.β-Hydroxybutyric sodium salt inhibition of growth hormone and prolactin secretion via the cAMP/PKA/CREB and AMPK signaling pathways in dairy cow anterior pituitary cells.Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with DyslipidaemiaThe White-Nose Syndrome Transcriptome: Activation of Anti-fungal Host Responses in Wing Tissue of Hibernating Little Brown Myotis.High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.Niacin in cardiovascular disease: recent preclinical and clinical developmentsA novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2.Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review.BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-κB activationNew evidence for nicotinic acid treatment to reduce atherosclerosis.Molecular biology of atherosclerosis.Adiponectin and lipoprotein metabolism.Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.Trans-cinnamic acid increases adiponectin and the phosphorylation of AMP-activated protein kinase through G-protein-coupled receptor signaling in 3T3-L1 adipocytes.Pleiotropic effects of niacin: Current possibilities for its clinical use.Constitutive expression of HCA(2) in human retina and primary human retinal pigment epithelial cells.Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin.Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy.Action of nicotinic acid on the reversion of hypoxic-inflammatory link on 3T3-L1 adipocytes.Butyrate attenuates lipolysis in adipocytes co-cultured with macrophages through non-prostaglandin E2-mediated and prostaglandin E2-mediated pathways.Nicotinic acid increases adiponectin secretion from differentiated bovine preadipocytes through G-protein coupled receptor signaling.Impaired glucose tolerance in low-carbohydrate diet: maybe only a physiological state.Glucose intolerance induced by glucocorticoid excess is further impaired by co-administration with β-hydroxy-β-methylbutyrate in rats.
P2860
Q26382049-D94CEB45-7BEA-440E-AE29-714056487665Q26746677-D7CF68E4-9FC9-48AD-B400-719CA21C4505Q26764724-DFFD4F8A-162C-4A11-AC76-959E00E8A928Q27002774-9CAE6C05-7E14-4730-AECF-602D9B4A9E2CQ28304559-7AD00AAD-CF01-43F7-8E97-E37AB2056E75Q30519552-D4838BF5-A271-48DE-B6A3-94924D25275BQ33601233-DC4BF1D2-F2D8-4F62-96C9-FDBE5EF67F48Q33849617-A1999C1B-DCC8-4E29-9DEA-E96CD76449A0Q34167803-4DD986B4-86D4-461F-AA3A-112A762A4C54Q34171831-4B4E00A5-FBEF-458A-A555-84C322AEE687Q34221038-CBFF9BC7-729F-4538-8C7B-36939B1DDA15Q34624990-7C390A39-BA1A-4C62-8372-45EA48239F27Q34877922-825D490B-F214-4A3B-B8A6-0551BC6DF8CDQ34963733-0146C8B7-66AB-4315-A3BF-9F76C206CA4CQ35039619-F1F65E13-23B5-4308-AE06-BD67B5209E84Q35101789-B295CEF5-3864-48D5-98F9-A8A318D44BBBQ35132366-D8189CC2-F08C-4063-86FA-4C76EA38EFFEQ35139230-1FEC2638-552F-49F7-A56E-9C0ADA41000CQ35598833-C094AAD8-8832-4C34-913F-1F5FCDEE2CCAQ35794927-1747EACA-C331-4F83-81DA-6F192B1411D0Q35844499-7C99A371-FB8D-44AD-B2BB-5C00942E0715Q36084389-6DFD69A2-2B09-43B4-ABE4-35CDABA0F86EQ36454274-8000C5F1-2AD6-430A-B74D-6C0752700CA2Q37508569-B7BC1791-1984-4AC3-A298-A63E4E0598A0Q37667487-67C18E3C-7B6E-4CF4-8D51-A90EA4E8F97CQ37720336-56B682E6-8119-48D1-8867-0F22F5E360F8Q37799365-2E4161CF-4488-4DE5-9DE2-374AA0288B3EQ38125279-12840356-8224-42C6-980A-8D4EA5E0295AQ38129920-9FB5ADA3-BDDA-40B1-9616-0A793D812011Q38175934-FDFE6410-9D01-4DB9-83D1-445DD856A888Q38345638-F87B9C10-3950-4470-BBB1-D87F89F07519Q38810790-EE80CF43-C7B4-410F-9188-BC7AA088F145Q39064720-F1039E8D-A667-4006-B71E-5F3DDBF09EA3Q39635867-18430D67-523C-453D-BB40-CD170359E7E3Q40154290-553EB760-F12D-475D-BB31-7FA3F2015772Q41256481-7567C5BD-FF28-4F51-8174-8F2A9DB5B879Q41952733-9F2829A5-C42D-4F56-9F27-BFF3D64E5574Q42584211-28490CF7-C131-458E-9246-C0F368B394F6Q45362687-AD04A48B-41A1-4879-8FE4-69225D541A4AQ46476511-88D8813A-4927-48D2-AF3A-CC59D1621808
P2860
Niacin stimulates adiponectin secretion through the GPR109A receptor
description
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
scientific journal article
@en
vedecký článok (publikovaný 2009/03/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/03/01)
@nl
наукова стаття, опублікована в березні 2009
@uk
مقالة علمية (نشرت في مارس 2009)
@ar
name
Niacin stimulates adiponectin secretion through the GPR109A receptor
@ast
Niacin stimulates adiponectin secretion through the GPR109A receptor
@en
Niacin stimulates adiponectin secretion through the GPR109A receptor
@nl
type
label
Niacin stimulates adiponectin secretion through the GPR109A receptor
@ast
Niacin stimulates adiponectin secretion through the GPR109A receptor
@en
Niacin stimulates adiponectin secretion through the GPR109A receptor
@nl
prefLabel
Niacin stimulates adiponectin secretion through the GPR109A receptor
@ast
Niacin stimulates adiponectin secretion through the GPR109A receptor
@en
Niacin stimulates adiponectin secretion through the GPR109A receptor
@nl
P2093
P2860
P3181
P1476
Niacin stimulates adiponectin secretion through the GPR109A receptor
@en
P2093
Eric P. Plaisance
Guoqing Cao
Martina Lukasova
Robert L. Judd
Youyan Zhang
P2860
P304
P3181
P356
10.1152/AJPENDO.91004.2008
P577
2009-03-01T00:00:00Z